Condition: Urologic Diseases · Male Urogenital Diseases · Urethral Stricture · Sponsor: Wake Forest University Health Sciences
This is a Phase I clinical study to determine the safety and efficacy of using autologous, engineered urethral constructs for the treatment of urethral strictures in adult males. The proposed study design is a prospective non-randomized and uncontrolled single-center investigation. Autologous urothelial cells (UCs) and smooth muscle cells (SMCs), obtained from enrolled male subjects' bladder tissue samples, will be culture expanded in vitro and used to seed tubular PGA scaffolds to create autologous urethral constructs for the repair of urethral strictures.
This description comes directly from the study's public registry record.
Mary-Clare Day, RN, BSN · 336-713-1343 · Maryclare.Day@advocatehealth.org
Always discuss trial participation with your own doctor first.
| University of California San Francisco | San Francisco, California, United States | Not Yet Recruiting |
| Wake Forest Institute for Regenerative Medicine (WFIRM) | Winston-Salem, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03258658